According to our latest study, titled “Human Identification Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and Services, Technology, Application, and End User,” the global human identification market is expected to grow from 1,827.02 million in 2021 to US$ 3,900.24 million by 2028. It is estimated to rise at a CAGR of 11.4% from 2021 to 2028.
Download PDF Sample Copy at: https://www.theinsightpartners.com/sample/TIPRE00005918/
The government initiatives for forensic programs and the novel sampling methods and portable equipment supporting DNA phenotyping, immunochromatography, geolocation, and other advanced forensic techniques are contributing to the human identification market growth. However, the high cost associated with instruments used in genomic studies restrain the market growth.
Based on products and services, the human identification market is segmented into consumables, services, instruments, and software. The consumables segment dominated the global market in 2021 and is anticipated to register the highest during the forecast period. Consumables are fundamental kits and chemicals required for human identification procedures, such as capillary electrophoresis, microfluidics, polymerase chain reaction (PCR), nucleic acid purification and extraction, automated liquid handling, microarrays, next-generation sequencing (NGS), rapid DNA analysis, and others
Impact of COVID-19 Pandemic on Human Identification Market
As the COVID-19 crisis moved forward, healthcare professionals realized that developing novel therapies using innovative technologies was essential to mitigate this unprecedented crisis. The treatment against COVID 19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the genome editing-related market as US FDA has recently approved the use of plasma therapy for critically ill COVID 19 patients. Upcoming stem cell therapies to boost patients' immune systems and eliminate the virus will offer significant growth prospects for the market. For instance, Lattice Biologics, in collaboration with Alumina Partners, has been accelerating phase 1 clinical trials for its stem cell-based AminioBoost therapies of COVID-19. Moreover, the mRNA-based vaccines against the COVID19 have been given emergency use authorization by the regulatory agencies in the region. The active involvement of the government and the associated market players in exploring opportunities for genome editing-related products and services is expected to drive such developments which will add to the future demand for the market in the forecast period
Thermo Fisher Scientific Inc.; Promega Corporation; Bio-Rad Laboratories, Inc.; QIAGEN; General Electric Company; llumina, Inc.; Eurofins Scientific; Agilent Technologies, Inc.; Hamilton Company; and LGC Limited are a few leading companies operating in the global human identification market.
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
